COHBAR, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 62 rows, 62 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-07-11: Reporting owner Tozzo Stephanie; Form 4; Security Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-12-29: Reporting owner Biunno Jeffrey Francis; Form 4; Security Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-12-29: Reporting owner Sarret Joseph J.; Form 4; Security Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-09-14: Reporting owner Yun Joanne; Form 4; Security Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-07-11 | Tozzo Stephanie Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.20 exercise price | 2022-07-12 | |
| 2021-12-29 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.34 exercise price | 2022-01-03 | |
| 2021-12-29 | Sarret Joseph J. Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +650,000 650,000 owned after | $1.35 exercise price | 2022-01-03 | |
| 2021-09-14 | Yun Joanne Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.18 exercise price | 2021-09-15 | |
| 2021-08-16 | Nast Carol Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.10 exercise price | 2021-08-17 | |
| 2021-08-11 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 750,000 owned after | $0.73 exercise price | 2021-08-13 | |
| 2021-06-16 | Amatruda John Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.36 exercise price | 2021-07-08 | |
| 2021-05-03 | Sarret Joseph J. Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,600,000 2,600,000 owned after | $1.35 exercise price | 2021-05-20 | |
| 2021-04-26 | Petkevich Misha Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-04-26 | GREENWOOD DAVID Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-04-26 | GARDNER PHYLLIS Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-04-26 | FITZGERALD ALBION Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-04-26 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-04-26 | Cohen Pinchas Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-04-26 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-04-26 | Barzilai Nir Yacov Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.38 exercise price | 2021-04-28 | |
| 2021-02-16 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 760,000 owned after | $0.73 exercise price | 2021-02-18 | |
| 2020-08-06 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 770,000 owned after | $0.73 exercise price | 2020-08-10 | |
| 2020-06-15 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 780,000 owned after | $0.73 exercise price | 2020-06-17 | |
| 2020-05-15 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 790,000 owned after | $0.73 exercise price | 2020-05-18 | |
| 2020-04-22 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,700 800,000 owned after | $0.73 exercise price | 2020-04-23 | |
| 2020-04-21 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,300 804,700 owned after | $0.73 exercise price | 2020-04-23 | |
| 2020-02-24 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 314,377 owned after | $0.26 exercise price | 2020-02-24 | |
| 2020-02-21 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 319,377 owned after | $0.26 exercise price | 2020-02-24 | |
| 2020-02-21 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 810,000 owned after | $0.73 exercise price | 2020-02-24 | |
| 2020-02-03 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 324,377 owned after | $0.26 exercise price | 2020-02-04 | |
| 2020-01-27 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 329,377 owned after | $0.26 exercise price | 2020-01-28 | |
| 2020-01-21 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 334,377 owned after | $0.26 exercise price | 2020-01-22 | |
| 2020-01-15 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 820,000 owned after | $0.73 exercise price | 2020-01-16 | |
| 2020-01-14 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,981 830,000 owned after | $0.73 exercise price | 2020-01-16 | |
| 2020-01-14 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 339,377 owned after | $0.26 exercise price | 2020-01-16 | |
| 2019-12-16 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,019 837,981 owned after | $0.73 exercise price | 2019-12-18 | |
| 2019-11-18 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 344,377 owned after | $0.26 exercise price | 2019-11-19 | |
| 2019-11-15 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 840,000 owned after | $0.73 exercise price | 2019-11-18 | |
| 2019-11-11 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 349,377 owned after | $0.26 exercise price | 2019-11-12 | |
| 2019-11-04 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 354,377 owned after | $0.26 exercise price | 2019-11-06 | |
| 2019-10-31 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 359,377 owned after | $0.26 exercise price | 2019-11-01 | |
| 2019-10-30 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,095 850,000 owned after | $0.73 exercise price | 2019-10-31 | |
| 2019-10-29 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −802 859,095 owned after | $0.73 exercise price | 2019-10-30 | |
| 2019-10-28 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −103 859,897 owned after | $0.73 exercise price | 2019-10-30 | |
| 2019-10-18 | Petkevich Misha Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.43 exercise price | 2019-10-22 | |
| 2019-05-31 | Calais Philippe Director | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $1.72 exercise price | 2019-06-04 | |
| 2019-05-16 | ENGLE STEVEN B Officer (Chief Executive Officer) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 1,500,000 owned after | $2.10 exercise price | 2019-05-17 | |
| 2019-04-19 | GREENWOOD DAVID Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $2.40 exercise price | 2019-04-23 | |
| 2019-02-08 | GARDNER PHYLLIS Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $3.15 exercise price | 2019-02-12 | |
| 2018-12-06 | Calais Philippe Director, Officer (Interim Chief Executive Office) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,000 96,000 owned after | $3.57 exercise price | 2018-12-10 | |
| 2018-07-18 | Stern Jon Leland Director, Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $2.40 exercise price | 2018-07-20 | |
| 2018-07-18 | Cundy Kenneth C Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $2.40 exercise price | 2018-07-20 | |
| 2018-07-18 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $2.40 exercise price | 2018-07-20 | |
| 2018-06-06 | Calais Philippe Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $8.86 exercise price | 2018-06-07 | |
| 2018-05-18 | FITZGERALD ALBION Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +200,000 200,000 owned after | $6.04 exercise price | 2018-05-22 | |
| 2018-03-25 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (right-to-buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $5.30 exercise price | 2018-03-27 | |
| 2017-12-06 | Amatruda John Director | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $4.60 exercise price | 2017-12-08 | |
| 2017-01-29 | Stern Jon Leland Director, Officer (Chief Operating Officer) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $2.40 exercise price | 2017-01-31 | |
| 2017-01-29 | FITZGERALD ALBION Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $2.40 exercise price | 2017-01-31 | |
| 2016-03-07 | ALLEN SIMON Officer (Chief Executive Officer) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,132,000 1,132,000 owned after | $1.55 exercise price | 2016-03-08 | |
| 2015-01-06 | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +127,532 364,377 owned after | $0.26 exercise price | 2015-01-06 | |
| 2014-12-19 holding as of filing | Stern Jon Leland Director, Officer (Chief Executive Officer) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $0.26 exercise price | 2014-12-19 | ||
| 2014-12-19 holding as of filing | Goldberg Marc E. Director | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $0.73 exercise price | 2014-12-19 | ||
| 2014-12-19 holding as of filing | FITZGERALD ALBION Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.73 exercise price | 2014-12-19 | ||
| 2014-12-19 holding as of filing | Cundy Kenneth C Officer (Chief Scientific Officer) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $0.73 exercise price | 2014-12-19 | ||
| 2014-12-19 holding as of filing | Biunno Jeffrey Francis Officer (CFO, Treasurer and Secretary) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $0.26 exercise price | 2014-12-19 |